CORTICOSTEROIDS AND BACTERIAL CORNEAL ULCERS

CORTICOSTEROIDS AND BACTERIAL CORNEAL ULCERS
Arthur Cummings
Published: Thursday, June 11, 2015

Topical corticosteroids should not be part of the initial treatment of bacterial corneal ulcers, according to a study presented at the 2015 European Society of Ophthalmology (SOE) meeting in Vienna.

"It is preferable not to use corticosteroids until the infecting organism has been culture-identified, otherwise we risk doing more harm than good," said Professor Joseph Frucht-Pery of Hadassah University Hospital,  Jerusalem, Israel.

For infection involving the visual axis, Prof. Frucht-Pery said that corticosteroids can be used at least two to three days after improvement with topical antibiotics and, again, preferably after identification of the pathogen. In cases of peripheral ulcers. steroids should be used only occasionally, he added.

Because of the risks associated with their misuse, topical corticosteroids should not be used by general ophthalmologists in community clinics, advised Prof. Frucht-Pery. "These cases should be referred and treated in hospital clinics or by cornea experts," he said.

Latest Articles
ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...

Should Fuchs’ Dystrophy Patients Get Premium Lenses?

Patients’ demand for premium IOLs despite contraindications pose a challenge in Fuchs’ dystrophy treatment.

Read more...

Avoiding Posterior Capsule Rupture

Imaging may help, but surgical technique is key for managing posterior polar cataracts.

Read more...